ロード中...
Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit
Clinical observations stemming from widespread employment of restorative L-3,4-dihydroxyphenylalanine (L-DOPA) therapy for management of dyskinesia in Parkinson’s Disease (PD) patients implicate a regulatory role for endogenous morphine in central nervous system dopamine neurotransmission. Reciproca...
保存先:
主要な著者: | , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
International Scientific Literature, Inc.
2012
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3560700/ https://ncbi.nlm.nih.gov/pubmed/22847214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.883259 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|